Lashly & Baer, P.C.

DEA Provides Fourth Extension of Rules Allowing Telemedicine Prescribing of Controlled Substances

February, 2026: The use of telemedicine to prescribe controlled substances has seen a dramatic increase in recent years, accelerated by the COVID-19 pandemic and subsequent temporary flexibilities in regulations. On December 30, 2025, the U.S. Drug Enforcement Administration (DEA) and the Department of Health and Human Services published the fourth Read more